211 related articles for article (PubMed ID: 23921508)
1. Role of interleukin-6, its receptor and soluble gp130 in chronic lung disease of prematurity.
Chakraborty M; McGreal EP; Davies PL; Nowell MA; Jones S; Kotecha S
Neonatology; 2013; 104(3):161-7. PubMed ID: 23921508
[TBL] [Abstract][Full Text] [Related]
2. Altered pulmonary interleukin-6 signaling in preterm infants developing bronchopulmonary dysplasia.
von Bismarck P; Claass A; Schickor C; Krause MF; Rose-John S
Exp Lung Res; 2008 Dec; 34(10):694-706. PubMed ID: 19085566
[TBL] [Abstract][Full Text] [Related]
3. Dynamic expression of IL-6 trans-signalling molecules in the lungs of preterm baboons undergoing mechanical ventilation.
McGreal EP; Chakraborty M; Winter VT; Jones SA; Coalson JJ; Kotecha S
Neonatology; 2011; 100(2):130-8. PubMed ID: 21372595
[TBL] [Abstract][Full Text] [Related]
4. IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes.
Lee SY; Buhimschi IA; Dulay AT; Ali UA; Zhao G; Abdel-Razeq SS; Bahtiyar MO; Thung SF; Funai EF; Buhimschi CS
J Immunol; 2011 Mar; 186(5):3226-36. PubMed ID: 21282511
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 and its receptors: a highly regulated and dynamic system.
Wolf J; Rose-John S; Garbers C
Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424
[TBL] [Abstract][Full Text] [Related]
6. Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling.
Hashizume M; Mihara M
Rheumatol Int; 2009 Feb; 29(4):397-401. PubMed ID: 18802703
[TBL] [Abstract][Full Text] [Related]
7. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
[TBL] [Abstract][Full Text] [Related]
8. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
[TBL] [Abstract][Full Text] [Related]
9. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
[TBL] [Abstract][Full Text] [Related]
10. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility.
Sherwin JR; Smith SK; Wilson A; Sharkey AM
J Clin Endocrinol Metab; 2002 Aug; 87(8):3953-60. PubMed ID: 12161539
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of IL-6 and soluble IL-6 receptor by neutrophil derived serine proteases in cystic fibrosis.
McGreal EP; Davies PL; Powell W; Rose-John S; Spiller OB; Doull I; Jones SA; Kotecha S
Biochim Biophys Acta; 2010; 1802(7-8):649-58. PubMed ID: 20438838
[TBL] [Abstract][Full Text] [Related]
12. Age-related increased prevalence of asthma and nasal polyps in chronic rhinosinusitis and its association with altered IL-6 trans-signaling.
Cho SH; Kim DW; Lee SH; Kolliputi N; Hong SJ; Suh L; Norton J; Hulse KE; Seshadri S; Conley DB; Kern RC; Tan BK; Peters A; Grammer LC; Schleimer RP
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):601-6. PubMed ID: 26266960
[TBL] [Abstract][Full Text] [Related]
13. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.
Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226
[TBL] [Abstract][Full Text] [Related]
14. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
[TBL] [Abstract][Full Text] [Related]
15. [Determination of serum soluble interleukin-6 receptor and soluble gp130 levels in patient with pregnancy induced hypertension and its significance].
Li Y; Wang Y; Qi L
Zhonghua Fu Chan Ke Za Zhi; 2001 Jan; 36(1):18-9. PubMed ID: 11778537
[TBL] [Abstract][Full Text] [Related]
16. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity.
Kotecha S; Wilson L; Wangoo A; Silverman M; Shaw RJ
Pediatr Res; 1996 Aug; 40(2):250-6. PubMed ID: 8827773
[TBL] [Abstract][Full Text] [Related]
17. Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps.
Peters AT; Kato A; Zhang N; Conley DB; Suh L; Tancowny B; Carter D; Carr T; Radtke M; Hulse KE; Seshadri S; Chandra R; Grammer LC; Harris KE; Kern R; Schleimer RP
J Allergy Clin Immunol; 2010 Feb; 125(2):397-403.e10. PubMed ID: 20159251
[TBL] [Abstract][Full Text] [Related]
18. Development of a monoclonal antibody-based enzyme-linked immunoabsorbent assay for the binding of gp130 to the IL-6/IL-6R complex and its competitive inhibition.
Scheller J; Kovaleva M; Rabe B; Eichler J; Kallen KJ; Rose-John S
J Immunol Methods; 2004 Aug; 291(1-2):93-100. PubMed ID: 15345308
[TBL] [Abstract][Full Text] [Related]
19. Increased IL-6 and Potential IL-6 trans-signalling in the airways after an allergen challenge.
Esnault S; Khosravi M; Kelly EA; Liu LY; Bochkov YA; Tattersall MC; Jarjour NN
Clin Exp Allergy; 2021 Apr; 51(4):564-573. PubMed ID: 33471392
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection.
Migita K; Abiru S; Maeda Y; Daikoku M; Ohata K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
Hum Immunol; 2006; 67(1-2):27-32. PubMed ID: 16698422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
